BioCentury
ARTICLE | Clinical News

HylatopicPlus Emollient Foam: Postmarketing study data

July 4, 2011 7:00 AM UTC

An open-label postmarketing study in 30 patients showed that HylatopicPlus Emollient Foam produced 67.9% improvement in IGA scores vs. 63.1% for Elidel pimecrolimus. At week 4, 82% of patients receiving HylatopicPlus were rated as "clear" or "almost clear" vs. 71% for Elidel. Data were published in the Journal of Drugs in Dermatology. ...